Completed PHASE2 INTERVENTIONAL 2-arm NCT02547519

Pre-POINT-Early Study

Pilot Study Using Oral Insulin at Early Age for Immune Efficacy in Primary Prevention of Type 1 Diabetes

Sponsor: German Center for Diabetes Research

Updated 8 times since 2017 Last updated: Feb 12, 2018 Started: Aug 31, 2015 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Diabetes Mellitus, Type 1 and is currently completed. German Center for Diabetes Research leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Nov 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Nov 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Mar 2018 — Jun 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Feb 2017 — Mar 2018 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

German Center for Diabetes Research
Helmholtz Zentrum München
Ludwig-Maximilians - University of Munich
Technical University of Munich
Technische Universität Dresden

Data source: Technical University of Munich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• München, Germany